<DOC>
	<DOCNO>NCT01220063</DOCNO>
	<brief_summary>The purpose study study stereotactic radiotherapy dose 40 Gy 4 fraction 2 week concomitant 40 mg/m2 irinotecan ( 1st 3rd irradiation session ) .</brief_summary>
	<brief_title>RSHF Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<criteria>Age &gt; = 18 year Social Insurance Performance Index &lt; 2 Life expectancy &gt; 6 month adenocarcinoma colorectal ( histologically proven ) Metastases ( inoperable recurrent surgery ) , hepatic localization / lung ( 3 one organ metastasis 3 total two body metastatic ) . The large diameter metastasis &lt; ou = 6cm liver , &lt; = 6 cm lung . If multiple metastasis , sum maximum diameter 6cm &lt; ou = liver , &lt; ou = 6 cm lung . Lesion ( ) measurable ( ) evaluable ( ) CT le 3 week Patients must receive least one prior chemotherapy regimen contain 5FU â€¢ Patients may receive one line chemotherapy include irinotecan . bilirubin &lt; 1.5 x ULN AST ALT &lt; 5x ULN neutrophil &gt; 1.5x109 / L , platelets &gt; 100x109 / L , hemoglobin &gt; 9 g / dL TP , TCA Normal ( patient treat permanent implant ) Informed consent sign . contraindication administration irinotecan . History radiotherapy thoracoabdominalcons indicate irradiation . History invasive cancer treat period le 5 year ( basal cell carcinoma noninvasive cervical except ) Metastatic disease diffuse three metastasis liver / lung natural history disease ( exclude patient complete radiological response several metastasis although 13 residual treatment ( ) medical ( ) ) . Location ( ) tumor ( ) = CTV le 12 mm laterally le 15 mm craniocaudal , stomach , small intestine , esophagus , trachea , bronchi right left pulmonary artery right leave . Pregnancy breastfeed . Lack mean refusal use effective contraception men woman childbearing age . Any concomitant experimental treatment . Any concurrent anticancer therapy , immunotherapy hormonal therapy . Monitoring impossible psychological , sociological geographical distance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>RSHF</keyword>
	<keyword>Irinotecan</keyword>
	<keyword>Colorectal Cancer</keyword>
	<keyword>metastasis</keyword>
</DOC>